Long-Term Benefits of Composite Treatment Targe...

By HEOR Staff Writer

January 21, 2026

Sustained Composite Treatment Targets Enhance Clinical and Economic Outcomes in Type 2 Diabetes A recent modeling study examines the lon...
Navigating Economic Resilience Through Life Sciences Investment
EU Medicine Authorizations 2025: A Milestone for Innovation and Accessibility
FDA Updates Labeling on Febrile Seizure Risks in Influenza Vaccine for Children
Guiding Principles for Ethical AI Integration in Drug Development
Obesity Medication Guidelines: Evidence-Based Approaches to Effective Treatment
Equity-Based Pricing: Enhancing Value in Primary Care through Socioeconomic C...
EU Launches Joint Scientific Consultations to Enhance Health Technology Asses...
β-Blockers Myocardial Infarction: Reevaluating Their Role in Patients with Pr...
Epidyolex Spending in Portugal Exceeds €3 Million Amid Regulatory Delays
Empowering Leaders at the Global Pharma Executive Course: Navigating Industry...
Johnson & Johnson’s Medicine Access Agreement: Paving the Way for ...
NHS Cost-Effectiveness Thresholds Boost Drug Approvals and Innovation